![](/images/graphics-bg.png)
Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
Joint Authors
Source
Gastroenterology Research and Practice
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-16, 16 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-07-26
Country of Publication
Egypt
No. of Pages
16
Main Subjects
Abstract EN
There is increased investigation of the human microbiome as it relates to health and disease.
Dysbiosis is implicated in various clinical conditions including inflammatory bowel disease (IBD).
Probiotics have been explored as a potential treatment for IBD and other diseases.
The mechanism of action for probiotics has yet to be fully elucidated.
This paper discusses novel mechanisms of action for probiotics involving anti-inflammatory signaling pathways.
We highlight recent progress in probiotics and nuclear receptor signaling, such as peroxisome-proliferator-activated receptor gamma (PPARγ) and vitamin D receptor (VDR).
We also discuss future areas of investigation.
American Psychological Association (APA)
Yoon, Sonia S.& Sun, Jun. 2011. Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways. Gastroenterology Research and Practice،Vol. 2011, no. 2011, pp.1-16.
https://search.emarefa.net/detail/BIM-512502
Modern Language Association (MLA)
Yoon, Sonia S.& Sun, Jun. Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways. Gastroenterology Research and Practice No. 2011 (2011), pp.1-16.
https://search.emarefa.net/detail/BIM-512502
American Medical Association (AMA)
Yoon, Sonia S.& Sun, Jun. Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways. Gastroenterology Research and Practice. 2011. Vol. 2011, no. 2011, pp.1-16.
https://search.emarefa.net/detail/BIM-512502
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-512502